Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/7/2026

1. TTD
2. NET
3. ABNB
4. TEAM
5. FROG
6. DV
7. TWLO
8. CART
9. SPY
10. U

Go back to Can-Fite Updates on its Advanced Liver Cancer Pivotal Phase 3 Study
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.44 -0.12 (3.37%)
Previous Close $3.56    52 Week High $3.89 
Open $3.49    52 Week Low $1.85 
Day High $3.49    P/E N/A 
Day Low $3.39    EPS $0.00 
Volume 32,418       

CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.44 -0.12 (3.37%)
Previous Close $3.56    52 Week High $3.89 
Open $3.49    52 Week Low $1.85 
Day High $3.49    P/E N/A 
Day Low $3.39    EPS $0.00 
Volume 32,418